第一单位：
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.;Biotech Research & Innovation Centre and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.;Foundation for the Finnish Cancer Institute, Helsinki, Finland.
作者：
Heikki,Kuusanmäki [1]
;
Olli,Dufva [2]
;
Markus,Vähä-Koskela [3]
;
Aino-Maija,Leppä [4]
;
Jani,Huuhtanen [5]
;
Ida,Vänttinen [3]
;
Petra,Nygren [6]
;
Jay,Klievink [6]
;
Jonas,Bouhlal [6]
;
Petri,Pölönen [7]
;
Qi,Zhang [8]
;
Shady,Adnan-Awad [9]
;
Cristina,Mancebo-Pérez [3]
;
Joseph,Saad [3]
;
Juho,Miettinen [3]
;
Komal K,Javarappa [3]
;
Sofia,Aakko [3]
;
Tanja,Ruokoranta [3]
;
Samuli,Eldfors [10]
;
Merja,Heinäniemi [7]
;
Kim,Theilgaard-Mönch [11]
;
Ulla,Wartiovaara-Kautto [12]
;
Mikko,Keränen [13]
;
Kimmo,Porkka [14]
;
Marina,Konopleva [8]
;
Krister,Wennerberg [15]
;
Mika,Kontro [16]
;
Caroline A,Heckman [17]
;
Satu,Mustjoki [2]
作者单位：
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.;Biotech Research & Innovation Centre and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.;Foundation for the Finnish Cancer Institute, Helsinki, Finland.
[1]
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
[2]
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
[3]
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.;Division of Stem Cells and Cancer, German Cancer Research Center and DKFZ-ZMBH Alliance, Heidelberg, Germany.
[4]
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;Department of Computer Science, Aalto University, Espoo, Finland.
[5]
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
[6]
Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland.
[7]
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
[8]
Foundation for the Finnish Cancer Institute, Helsinki, Finland.;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
[9]
Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA.
[10]
Biotech Research & Innovation Centre and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.;Department of Hematology and Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
[11]
Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
[12]
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
[13]
Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.;Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
[14]
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.;Biotech Research & Innovation Centre and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.
[15]
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.;Foundation for the Finnish Cancer Institute, Helsinki, Finland.;Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
[16]
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.;iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland.
[17]
医学主题词
动物(Animals);小鼠(Mice);人类(Humans);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);细胞系, 肿瘤(Cell Line, Tumor);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);bcl-X蛋白质(bcl-X Protein);白血病, 原始巨核细胞, 急性(Leukemia, Megakaryoblastic, Acute);淋巴瘤, B细胞(Lymphoma, B-Cell);细胞分化(Cell Differentiation);细胞凋亡(Apoptosis)
DOI
10.1182/blood.2021011094
PMID
36508699
发布时间
2023-11-19
换一批
